grant

Editing Acetylation and Protein Homeostasis

Organization UNIVERSITY OF PENNSYLVANIALocation PHILADELPHIA, UNITED STATESPosted 1 Aug 2021Deadline 31 May 2026
NIHUS FederalResearch GrantFY202520S Catalytic Proteasome20S Core Proteasome20S Proteasome20S ProteosomeAPF-1ATP-Dependent Proteolysis Factor 1AcetylationAcetyltransferaseBiochemicalBiologicalBiological FunctionBiological ProcessBiologyBiophysicsCell BodyCellsChemicalsDeacetylaseDiseaseDisorderE1A Binding Protein p300E3 LigaseE3 Ubiquitin LigaseEP300EP300 geneEnzyme GeneEnzymesGene TranscriptionGenetic TranscriptionGoalsHMG-20HealthHigh Mobility Protein 20HumanKAT3BMacropainMacroxyproteinaseMetabolic Protein DegradationModern ManMolecularMulticatalytic ProteinasePathway interactionsPhosphorylationPost-Translational Modification Protein/Amino Acid BiochemistryPost-Translational ModificationsPost-Translational Protein ModificationPost-Translational Protein ProcessingPosttranslational ModificationsPosttranslational Protein ProcessingProductionProsomeProtacProteasomeProteasome Endopeptidase ComplexProtein AcetylationProtein DatabasesProtein ModificationProtein PhosphorylationProtein TurnoverProteinsProteolysis targeting chimericProteomicsProteosomeRNA ExpressionRNA SeqRNA sequencingRNAseqRegulationRegulatory Protein DegradationSystemTherapeuticTranscriptionUbiquitinUbiquitin Protein LigaseUbiquitin-Protein Ligase ComplexesUbiquitin-Protein Ligase E3Workbiologicbiophysical foundationbiophysical principlesbiophysical sciencesdesigndesigningexperimentexperimental researchexperimental studyexperimentshistone acetyltransferase p300insightmolecular recognitionmulticatalytic endopeptidase complexnew therapeutic approachnew therapeutic interventionnew therapeutic strategiesnew therapy approachesnew treatment approachnew treatment strategynon-histone proteinnonhistone proteinnovelnovel therapeutic approachnovel therapeutic interventionnovel therapeutic strategiesnovel therapy approachp300pathwayprotein degradationprotein homeostasisprotein protein interactionproteolysis targeting chimaeraproteolysis targeting chimeraproteostasisrecruittooltranscriptome sequencingtranscriptomic sequencingubiquitin-protein ligase
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Abstract
Protein homeostasis is crucial to maintain healthy cells and is predominantly controlled by the ubiquitin

proteasome system (UPS) whereby proteins are tagged with ubiquitin, via a cascade of 3 enzymes, resulting in

recognition by the proteasome and subsequent degradation. While some proteins are constitutively recognized

and degraded by this system, others are marked as substrates for the UPS by post-translational modifications

such as phosphorylation. Recently, acetylation of non-histone proteins has emerged as an important mechanism

of regulation for the ubiquitin-proteasome system, particularly at the level of E3 ligase substrate recognition.

Leveraging our expertise of the ubiquitin proteasome and protein-protein interactions we propose to elucidate

the molecular mechanisms and biological pathways resulting in acetylation driven modulation of protein

homeostasis (Project 1). Additionally, building on our previous work with proteolysis targeting chimera, we will

develop heterobifunctional approaches to modulate protein acetylation states as a novel mechanism to control

protein homeostasis for both the study of this fundamental biological regulation and as a potential therapeutic

approach (Project 2).

In Project 1, we will identify and characterize proteins with stability regulated at the level of post-translational

acetylation. Using proteomics experiments paired with RNA-Seq we will generate a database of proteins with

intracellular levels directly controlled by p300 driven acetylation, not altered at the level of transcription.

Furthermore, we will characterize the molecular recognition of acetyl degron substrates by the relevant E3

ligases using biophysical, biochemical and structural approaches, revealing unique insights into this mechanism

of protein homeostasis. In Project 2, we will develop heterobifunctional compounds which recruit an

acetyltransferase or deacetylase to a neo-substrate. Building on the concept of chemically induced post-

translational modifications, exemplified by proteolysis targeting chimera, we will identify the (de)acetylation

machinery most amenable to this approach via chemical biology approaches before designing and synthesising

compounds to edit acetylation in native systems.Together these projects provide insights into basic biological

processes regulating protein stability and a novel chemical biology approach to modify them.

Grant Number: 5R35GM142505-05
NIH Institute/Center: NIH

Principal Investigator: George Burslem

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →